CliffBio
small molecule

FETROJA

CEFIDEROCOL SULFATE TOSYLATE

Loss of exclusivitySeptember 2035latest FDA-listed patent expiry
CompanyShionogi →View the full company profile on CliffBio

Drug detail

Brand nameFETROJA
Active ingredientCEFIDEROCOL SULFATE TOSYLATE
StrengthEQ 1GM BASE/VIAL
Dosage formPOWDER
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalNovember 2019
Marketing statusRX

Listed patents

PatentExpiresType
10004750September 2035substance, product
9949982September 2035product
9238657November 2033substance, product

Regulatory exclusivity

CodeExpires
GAINNovember 2029
NCENovember 2024

More from Shionogi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found